Argenx
ARGX
#543
Rank
ยฃ27.22 B
Marketcap
ยฃ445.06
Share price
1.47%
Change (1 day)
49.29%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): ยฃ63.96 Million

According to Argenx 's latest financial reports the company's current earnings are ยฃ2.19 Billion. , an increase over its 2023 earnings that were of -ยฃ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 ยฃ63.58 M-127.97%
2023 -ยฃ0.23 Billion-58.25%
2022 -ยฃ0.55 Billion
2019 -ยฃ0.15 Billion124.95%
2018 -ยฃ66.07 Million132.04%
2017 -ยฃ28.47 Million54.86%
2016 -ยฃ18.39 Million33%
2015 -ยฃ13.83 Million13.63%
2014 -ยฃ12.17 Million46.25%
2013 -ยฃ8.32 Million